Previous studies from our laboratory have suggested that ICOS expression in tumor-infiltrating lymphocytes is correlated with beneficial outcome, but little is known about the role of ICOSL in NPC. The gene discussed is ICOS; the disease is nasopharyngeal carcinoma.